Skip to main content
Clinical Trials/NCT05985408
NCT05985408
Not Yet Recruiting
N/A

Left Ventricular Septal Pacing Based Rescue CRT Versus Right Ventricular Apical Pacing Based CRT for Chronic Heart Failure: a Randomized Controlled Trial

Fu Wai Hospital, Beijing, China1 site in 1 country40 target enrollmentSeptember 1, 2023

Overview

Phase
N/A
Intervention
Not specified
Conditions
Heart Failure
Sponsor
Fu Wai Hospital, Beijing, China
Enrollment
40
Locations
1
Primary Endpoint
left ventricular ejection fraction (LVEF)
Status
Not Yet Recruiting
Last Updated
2 years ago

Overview

Brief Summary

To find out whether left ventricular septal pacing (LVSP)-based cardiac resynchronization therapy (CRT) is superior to right ventricular apical pacing (RVAP)-based CRT in patients with failed left bundle branch pacing at the beginning of chronic heart failure.

Registry
clinicaltrials.gov
Start Date
September 1, 2023
End Date
September 1, 2025
Last Updated
2 years ago
Study Type
Interventional
Study Design
Parallel
Sex
All

Investigators

Sponsor
Fu Wai Hospital, Beijing, China
Responsible Party
Principal Investigator
Principal Investigator

Li Xiaofei

Doctor

Fu Wai Hospital, Beijing, China

Eligibility Criteria

Inclusion Criteria

  • Chronic heart failure, LVEF ≤35% after at least 3 months of guideline-optimized drug therapy, NYHA class II-IV with complete left bundle branch block (QRSd≥130 ms), OR Atrioventricular block with LVEF ≤ 50% with the indication of cardiac pacing;
  • Age between 18 and 90 years old;
  • The expected survival period is greater than 12 months;
  • Signed the informed consent form for the study.

Exclusion Criteria

  • Previous mechanical tricuspid valve replacement.
  • Previous pacemaker or other devices implanted and for device replacement or upgrading for this time.
  • Patients have a history of unstable angina, acute myocardial infarction, CABG, and PCI surgery within three months.
  • Persistent atrial fibrillation without AV block, the proportion of biventricular pacing is not expected to less than 95%.
  • Patients participated in any of the other studies at the same time, which may confound the results of this study.
  • Pregnancy, planning to become pregnant.
  • Patients with a history of heart transplantation.

Outcomes

Primary Outcomes

left ventricular ejection fraction (LVEF)

Time Frame: 12 months

LVEF evaluated by echocardiography,Bi-plane Simpson's method

left ventricular end-systolic volume (LVESV)

Time Frame: 12 months

LVESV evaluated by echocardiography

Secondary Outcomes

  • NT-proBNP(12 months)
  • paced QRSd duration.(12 months)
  • 6-minute hall walk distance(12 months)
  • All cause death(12 months)
  • Heart failure rehospitalization(12 months)
  • Rehospitalization for cardiovascular adverse events(12 months)
  • Malignant ventricular arrhythmias(12 months)

Study Sites (1)

Loading locations...

Similar Trials